These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29332614)

  • 1. Serelaxin for infant heart failure in congenital dilated cardiomyopathy.
    Myers PO; Bordessoule A; Tissot C
    Cardiol Young; 2018 May; 28(5):734-736. PubMed ID: 29332614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serelaxin attenuates renal inflammation and fibrosis in a mouse model of dilated cardiomyopathy.
    Giam B; Chu PY; Kuruppu S; Smith AI; Horlock D; Murali A; Kiriazis H; Du XJ; Kaye DM; Rajapakse NW
    Exp Physiol; 2018 Dec; 103(12):1593-1602. PubMed ID: 30311699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venoarterial Extracorporeal Membrane Oxygenation Support as a Bridge to Heart Transplant: Report of 3 Cases.
    Gedik E; Ulaş A; Ersoy Ö; Atar F; Camkıran Fırat A; Pirat A
    Exp Clin Transplant; 2016 Nov; 14(Suppl 3):121-124. PubMed ID: 27805530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxin for the Treatment of Acute Decompensated Heart Failure: Pharmacology, Mechanisms of Action, and Clinical Evidence.
    Ng TM; Goland S; Elkayam U
    Cardiol Rev; 2016; 24(4):194-204. PubMed ID: 26331289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.
    Metra M; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld L; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Prescott MF; Edwards C; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin T; Teerlink JR;
    J Am Coll Cardiol; 2013 Jan; 61(2):196-206. PubMed ID: 23273292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.
    Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld LR; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin TM; Metra M;
    Lancet; 2013 Jan; 381(9860):29-39. PubMed ID: 23141816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left Ventricular Noncompaction Cardiomyopathy Presenting with Heart Failure in a 35-Year-Old Man.
    Papadopoulos K; Petrou PM; Michaelides D
    Tex Heart Inst J; 2017 Aug; 44(4):260-263. PubMed ID: 28878579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serelaxin a novel treatment for acute heart failure.
    Castrini AI; Carubelli V; Lazzarini V; Bonadei I; Lombardi C; Metra M
    Expert Rev Clin Pharmacol; 2015; 8(5):549-57. PubMed ID: 26294074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-centred experience with levosimendan in paediatric decompensated dilated cardiomyopathy.
    Séguéla PE; Mauriat P; Mouton JB; Tafer N; Assy J; Poncelet G; Nubret K; Iriart X; Thambo JB
    Arch Cardiovasc Dis; 2015; 108(6-7):347-55. PubMed ID: 25863426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Dilated Cardiomyopathy Patients Do Not Meet Traditional Cardiac Resynchronization Criteria.
    Schiller O; Dham N; Greene EA; Heath DM; Alexander ME; Berul CI
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):885-889. PubMed ID: 25884372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
    Amorim S; Rodrigues J; Campelo M; Moura B; Martins E; Macedo F; Silva-Cardoso J; Maciel MJ
    Int J Cardiovasc Imaging; 2017 May; 33(5):605-613. PubMed ID: 28013418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse histologic remodeling after mechanical unloading of failing hearts in children with dilated cardiomyopathy.
    Kasten J; Rakheja D; Zhang S; Thankavel P; Das BB
    J Heart Lung Transplant; 2017 Nov; 36(11):1268-1271. PubMed ID: 28705646
    [No Abstract]   [Full Text] [Related]  

  • 13. Serelaxin, recombinant human relaxin-2, for heart failure patients: A systematic review and meta-analysis.
    Yu L; Cao L; Sun J; Li Z; Yao F; Zhou Y
    Medicine (Baltimore); 2018 Jun; 97(25):e11010. PubMed ID: 29923986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic and hemodynamic benefit of pentaerythrityl tetranitrate and hydralazine in a case of congestive heart failure.
    Gori T; Münzel T
    Clin Res Cardiol; 2009 Oct; 98(10):677-9. PubMed ID: 19644645
    [No Abstract]   [Full Text] [Related]  

  • 15. Serelaxin for the treatment of heart failure.
    Moin DS; Bloom MW; Papadimitriou L; Butler J
    Expert Rev Cardiovasc Ther; 2016 Jun; 14(6):667-75. PubMed ID: 27045761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upgraded heart failure therapy leads to an improved outcome of dilated cardiomyopathy in infants and toddlers.
    Rupp S; Apitz C; Tholen L; Latus H; Ostermayer SH; Schmidt D; Bauer J; Schranz D
    Cardiol Young; 2015 Oct; 25(7):1300-5. PubMed ID: 25498517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serelaxin : a potential new drug for the treatment of acute heart failure.
    Neverova N; Teerlink JR
    Expert Opin Investig Drugs; 2014 Jul; 23(7):1017-26. PubMed ID: 24865798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT; Kourea K; Panou F; Farmakis D; Paraskevaidis I; Ikonomidis I; Filippatos G; Kremastinos DT
    Am Heart J; 2008 Apr; 155(4):751.e1-7. PubMed ID: 18371487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal hemodynamic effects of serelaxin in patients with chronic heart failure: a randomized, placebo-controlled study.
    Voors AA; Dahlke M; Meyer S; Stepinska J; Gottlieb SS; Jones A; Zhang Y; Laurent D; Slart RH; Navis GJ
    Circ Heart Fail; 2014 Nov; 7(6):994-1002. PubMed ID: 25286914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
    J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.